Human Gene POLE3 (uc031tet.1)
  Description: Homo sapiens polymerase (DNA directed), epsilon 3, accessory subunit (POLE3), transcript variant 1, mRNA.
RefSeq Summary (NM_001278255): POLE3 is a histone-fold protein that interacts with other histone-fold proteins to bind DNA in a sequence-independent manner. These histone-fold protein dimers combine within larger enzymatic complexes for DNA transcription, replication, and packaging.[supplied by OMIM, Apr 2004].
Transcript (Including UTRs)
   Position: hg19 chr9:116,169,518-116,173,029 Size: 3,512 Total Exon Count: 5 Strand: -
Coding Region
   Position: hg19 chr9:116,171,091-116,172,573 Size: 1,483 Coding Exon Count: 4 

Page IndexSequence and LinksUniProtKB CommentsPrimersCTDGene Alleles
RNA-Seq ExpressionMicroarray ExpressionRNA StructureProtein StructureOther SpeciesGO Annotations
mRNA DescriptionsPathwaysOther NamesModel InformationMethods
Data last updated at UCSC: 2013-06-14

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr9:116,169,518-116,173,029)mRNA (may differ from genome)Protein (147 aa)
Gene SorterGenome BrowserOther Species FASTAVisiGeneGene interactionsTable Schema
AlphaFoldBioGPSEnsemblEntrez GeneExonPrimerGeneCards
H-INVHGNCHPRDLynxMGIneXtProt
OMIMPubMedReactomeUniProtKBWikipediaBioGrid CRISPR DB

-  Comments and Description Text from UniProtKB
  ID: DPOE3_HUMAN
DESCRIPTION: RecName: Full=DNA polymerase epsilon subunit 3; EC=2.7.7.7; AltName: Full=Arsenic-transactivated protein; Short=AsTP; AltName: Full=Chromatin accessibility complex 17 kDa protein; Short=CHRAC-17; Short=HuCHRAC17; AltName: Full=DNA polymerase II subunit 3; AltName: Full=DNA polymerase epsilon subunit p17;
FUNCTION: Forms a complex with DNA polymerase epsilon subunit CHRAC1 and binds naked DNA, which is then incorporated into chromatin, aided by the nucleosome-remodeling activity of ISWI/SNF2H and ACF1.
CATALYTIC ACTIVITY: Deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1).
SUBUNIT: Component of the epsilon DNA polymerase complex consisting of four subunits: POLE, POLE2, POLE3 and POLE4. Interaction with POLE4 is a prerequisite for further binding with POLE and POLE2. Interacts with CHRAC1. Together with CHRAC1, ACF1 and ISWI/SNF2H proteins, it forms the ISWI chromatin-remodeling complex, CHRAC.
INTERACTION: Q9Q2G4:ORF (xeno); NbExp=5; IntAct=EBI-744901, EBI-6248094; Q9NR33:POLE4; NbExp=3; IntAct=EBI-744901, EBI-867034;
SUBCELLULAR LOCATION: Nucleus (Potential).
TISSUE SPECIFICITY: Expressed in all tissues tested, including, heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas.
WEB RESOURCE: Name=NIEHS-SNPs; URL="http://egp.gs.washington.edu/data/pole3/";

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene           more ... click here to view the complete list

+  Common Gene Haplotype Alleles
  Press "+" in the title bar above to open this section.

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 40.22 RPKM in Brain - Cerebellar Hemisphere
Total median expression: 1091.42 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -95.90218-0.440 Picture PostScript Text
3' UTR -464.201573-0.295 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR003958 - CBFA_NFYB_domain
IPR009072 - Histone-fold

Pfam Domains:
PF00808 - Histone-like transcription factor (CBF/NF-Y) and archaeal histone

SCOP Domains:
47113 - Histone-fold

ModBase Predicted Comparative 3D Structure on Q9NRF9
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologGenome BrowserGenome BrowserGenome BrowserNo orthologNo ortholog
Gene DetailsGene Details Gene Details  
Gene SorterGene Sorter Gene Sorter  
 RGDEnsemblFlyBase  
 Protein SequenceProtein SequenceProtein Sequence  
 AlignmentAlignmentAlignment  

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0003677 DNA binding
GO:0003887 DNA-directed DNA polymerase activity
GO:0005515 protein binding
GO:0016740 transferase activity
GO:0016779 nucleotidyltransferase activity
GO:0046982 protein heterodimerization activity

Biological Process:
GO:0000082 G1/S transition of mitotic cell cycle
GO:0006260 DNA replication
GO:0043966 histone H3 acetylation
GO:0071897 DNA biosynthetic process

Cellular Component:
GO:0005634 nucleus
GO:0005654 nucleoplasm
GO:0005671 Ada2/Gcn5/Ada3 transcription activator complex
GO:0008622 epsilon DNA polymerase complex


-  Descriptions from all associated GenBank mRNAs
  AK074629 - Homo sapiens cDNA FLJ90148 fis, clone HEMBB1001959, weakly similar to CCAAT-BINDING TRANSCRIPTION FACTOR SUBUNIT A.
AK096050 - Homo sapiens cDNA FLJ38731 fis, clone KIDNE2010739, moderately similar to Homo sapiens CHRAC17 (CHRAC17) mRNA.
AF070640 - Homo sapiens clone 24781 mRNA sequence.
BC003166 - Homo sapiens polymerase (DNA directed), epsilon 3 (p17 subunit), mRNA (cDNA clone MGC:4348 IMAGE:2822216), complete cds.
BC004170 - Homo sapiens polymerase (DNA directed), epsilon 3 (p17 subunit), mRNA (cDNA clone MGC:2725 IMAGE:2822216), complete cds.
AK092840 - Homo sapiens cDNA FLJ35521 fis, clone SPLEN2001278, highly similar to Homo sapiens CHRAC17 (CHRAC17) mRNA.
AK074782 - Homo sapiens cDNA FLJ90301 fis, clone NT2RP2000610, weakly similar to CCAAT-BINDING TRANSCRIPTION FACTOR SUBUNIT A.
AK074762 - Homo sapiens cDNA FLJ90281 fis, clone NT2RP1000468, weakly similar to CCAAT-BINDING TRANSCRIPTION FACTOR SUBUNIT A.
JD296304 - Sequence 277328 from Patent EP1572962.
JD550529 - Sequence 531553 from Patent EP1572962.
JD353672 - Sequence 334696 from Patent EP1572962.
JD070593 - Sequence 51617 from Patent EP1572962.
JD406385 - Sequence 387409 from Patent EP1572962.
JD425945 - Sequence 406969 from Patent EP1572962.
JD255863 - Sequence 236887 from Patent EP1572962.
JD454712 - Sequence 435736 from Patent EP1572962.
JD292847 - Sequence 273871 from Patent EP1572962.
JD562851 - Sequence 543875 from Patent EP1572962.
JD551364 - Sequence 532388 from Patent EP1572962.
JD148686 - Sequence 129710 from Patent EP1572962.
JD202203 - Sequence 183227 from Patent EP1572962.
JD160224 - Sequence 141248 from Patent EP1572962.
JD247760 - Sequence 228784 from Patent EP1572962.
JD404172 - Sequence 385196 from Patent EP1572962.
JD525868 - Sequence 506892 from Patent EP1572962.
JD399753 - Sequence 380777 from Patent EP1572962.
JD424439 - Sequence 405463 from Patent EP1572962.
JD536793 - Sequence 517817 from Patent EP1572962.
JD255371 - Sequence 236395 from Patent EP1572962.
JD392307 - Sequence 373331 from Patent EP1572962.
JD214118 - Sequence 195142 from Patent EP1572962.
JD254475 - Sequence 235499 from Patent EP1572962.
JD123885 - Sequence 104909 from Patent EP1572962.
JD021812 - Sequence 2836 from Patent EP1572962.
JD027916 - Sequence 8940 from Patent EP1572962.
JD469593 - Sequence 450617 from Patent EP1572962.
JD073193 - Sequence 54217 from Patent EP1572962.
JD381058 - Sequence 362082 from Patent EP1572962.
JD316987 - Sequence 298011 from Patent EP1572962.
JD313207 - Sequence 294231 from Patent EP1572962.
JD453930 - Sequence 434954 from Patent EP1572962.
JD083761 - Sequence 64785 from Patent EP1572962.
AF226077 - Homo sapiens CHRAC17 (CHRAC17) mRNA, complete cds.
AY720898 - Homo sapiens arsenic transactivated protein mRNA, complete cds.
JF432738 - Synthetic construct Homo sapiens clone IMAGE:100073982 polymerase (DNA directed), epsilon 3 (p17 subunit) (POLE3) gene, encodes complete protein.
KJ894010 - Synthetic construct Homo sapiens clone ccsbBroadEn_03404 POLE3 gene, encodes complete protein.
AB527738 - Synthetic construct DNA, clone: pF1KB7911, Homo sapiens POLE3 gene for polymerase (DNA directed), epsilon 3, without stop codon, in Flexi system.

-  Biochemical and Signaling Pathways
  KEGG - Kyoto Encyclopedia of Genes and Genomes
hsa00230 - Purine metabolism
hsa00240 - Pyrimidine metabolism
hsa01100 - Metabolic pathways
hsa03030 - DNA replication
hsa03410 - Base excision repair
hsa03420 - Nucleotide excision repair

Reactome (by CSHL, EBI, and GO)

Protein Q9NRF9 (Reactome details) participates in the following event(s):

R-HSA-68960 DNA polymerase epsilon binds at the origin
R-HSA-68913 The primase component of DNA polymerase:primase synthesizes a 6-10 nucleotide RNA primer at the origin
R-HSA-174425 The primase component of DNA polymerase:primase synthesizes a 6-10 nucleotide RNA primer on the G strand of the telomere
R-HSA-68914 DNA polymerase alpha:primase binds at the origin
R-HSA-5653838 POLD,POLE binds deISGylated PCNA after TLS
R-HSA-5652009 RAD18:UBE2B or RBX1:CUL4:DDB1:DTL monoubiquitinates PCNA
R-HSA-110364 PCNA:POLD,POLE:RPA:RFC and FEN1 bind APEX1
R-HSA-5651992 PCNA-containing replication complex binds damaged dsDNA
R-HSA-5651809 LIG1, APEX1 and PCNA:POLD,POLE:RPA:RFC dissociate from repaired DNA
R-HSA-5653840 POLD,POLE complete replication of damaged DNA after TLS
R-HSA-5690213 DNA polymerases delta, epsilon or kappa bind the GG-NER site
R-HSA-6782211 DNA polymerases delta, epsilon or kappa bind the TC-NER site
R-HSA-110368 POLD,POLE-mediated DNA strand displacement synthesis
R-HSA-110371 LIG1 binds APEX1 and PCNA at SSB
R-HSA-110363 FEN1 bound to PCNA and APEX1 cleaves flap ssDNA
R-HSA-5651805 LIG1 bound to APEX1 and PCNA ligates SSB
R-HSA-5652005 RAD18:UBE2B or RBX1:CUL4:DDB1:DTL ubiquitin ligase complex binds PCNA:POLD,POLE:RPA:RFC associated with damaged dsDNA
R-HSA-5693593 D-loop extension by DNA polymerases
R-HSA-5690997 Ligation of newly synthesized repair patch to incised DNA in GG-NER
R-HSA-6782227 Ligation of newly synthesized repair patch to incised DNA in TC-NER
R-HSA-5690988 3'-incision of DNA by ERCC5 (XPG) in GG-NER
R-HSA-5691001 Repair DNA synthesis of ~27-30 bases long patch by POLD, POLE or POLK in GG-NER
R-HSA-6782224 3' incision by ERCC5 (XPG) in TC-NER
R-HSA-6782208 Repair DNA synthesis of ~27-30 bases long patch by POLD, POLE or POLK in TC-NER
R-HSA-68962 Activation of the pre-replicative complex
R-HSA-68952 DNA replication initiation
R-HSA-174430 Telomere C-strand synthesis initiation
R-HSA-5656169 Termination of translesion DNA synthesis
R-HSA-110314 Recognition of DNA damage by PCNA-containing replication complex
R-HSA-69002 DNA Replication Pre-Initiation
R-HSA-69206 G1/S Transition
R-HSA-69239 Synthesis of DNA
R-HSA-174417 Telomere C-strand (Lagging Strand) Synthesis
R-HSA-5651801 PCNA-Dependent Long Patch Base Excision Repair
R-HSA-5696400 Dual Incision in GG-NER
R-HSA-6782135 Dual incision in TC-NER
R-HSA-110313 Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template
R-HSA-73893 DNA Damage Bypass
R-HSA-68874 M/G1 Transition
R-HSA-453279 Mitotic G1-G1/S phases
R-HSA-69242 S Phase
R-HSA-69306 DNA Replication
R-HSA-180786 Extension of Telomeres
R-HSA-110373 Resolution of AP sites via the multiple-nucleotide patch replacement pathway
R-HSA-5696399 Global Genome Nucleotide Excision Repair (GG-NER)
R-HSA-6781827 Transcription-Coupled Nucleotide Excision Repair (TC-NER)
R-HSA-73894 DNA Repair
R-HSA-69278 Cell Cycle (Mitotic)
R-HSA-157579 Telomere Maintenance
R-HSA-5685942 HDR through Homologous Recombination (HRR)
R-HSA-73933 Resolution of Abasic Sites (AP sites)
R-HSA-5696397 Gap-filling DNA repair synthesis and ligation in GG-NER
R-HSA-6782210 Gap-filling DNA repair synthesis and ligation in TC-NER
R-HSA-5696398 Nucleotide Excision Repair
R-HSA-1640170 Cell Cycle
R-HSA-73886 Chromosome Maintenance
R-HSA-5693567 HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)
R-HSA-73884 Base Excision Repair
R-HSA-5693538 Homology Directed Repair
R-HSA-5693532 DNA Double-Strand Break Repair

-  Other Names for This Gene
  Alternate Gene Symbols: CHRAC17, DPOE3_HUMAN, NM_001278255, NP_001265184, Q5W0U1, Q8N758, Q8NCE5, Q9NR32, Q9NRF9, uc004bhn.2
UCSC ID: uc031tet.1
RefSeq Accession: NM_001278255
Protein: Q9NRF9 (aka DPOE3_HUMAN or DPE3_HUMAN)
CCDS: CCDS6795.1

-  Gene Model Information
 
category: coding nonsense-mediated-decay: no RNA accession: NM_001278255.1
exon count: 5CDS single in 3' UTR: no RNA size: 2258
ORF size: 444CDS single in intron: no Alignment % ID: 100.00
txCdsPredict score: 1061.00frame shift in genome: no % Coverage: 98.94
has start codon: yes stop codon in genome: no # of Alignments: 1
has end codon: yes retained intron: no # AT/AC introns 0
selenocysteine: no end bleed into intron: 0# strange splices: 0
Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.